# OnCo record paper-hulscher-ivermectin-mebendazole-cohort-anticancer-res-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hulscher-ivermectin-mebendazole-cohort-anticancer-res-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hulscher-ivermectin-mebendazole-cohort-anticancer-res-2026" ;
  schema:name "Real-world clinical outcomes of ivermectin and mebendazole in cancer patients: results from a prospective observational cohort (with 2026 expression of concern)"@en ;
  schema:description "A telemedicine company's survey of patients it prescribed ivermectin and mebendazole reported that most felt better; the journal has attached an expression of concern while it checks whether the diagnoses, the regressions and the ethical approval can be verified."@en ;
  schema:url <https://onco.cc/key-papers/paper-hulscher-ivermectin-mebendazole-cohort-anticancer-res-2026/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.21873/anticanres.18194>, <https://doi.org/10.21873/anticanres.18276>, <https://pubmed.ncbi.nlm.nih.gov/42203321/>, <https://pubmed.ncbi.nlm.nih.gov/42300708/> ;
  schema:sameAs <https://doi.org/10.21873/anticanres.18194> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Hulscher N, Victory K, Thorp JA, et al." ;
  onco:technologies <https://onco.cc/technologies/fenbendazole-ivermectin-repurposing-claims/> ;
  onco:drugs <https://onco.cc/drugs/ivermectin/>, <https://onco.cc/drugs/mebendazole/> ;
  onco:terms <https://onco.cc/terms/off-label/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-misinformation/> ;
  onco:journals <https://onco.cc/journals/anticancer-research/> .